Products

Personalized Therapy Comfort Settings (PTCS)
ResMed
Clinical Decision Support & Reference
ResMed's Smart Comfort (Personalized Therapy Comfort Settings - PTCS) is an FDA-cleared, AI-enabled digital tool that recommends personalized comfort settings for CPAP therapy, designed to enhance adherence for new users of AirSense 11 devices.

See all 1 product →

About ResMed

ResMed is a global leader in digital health and medical equipment, dedicated to pioneering innovative solutions that empower millions worldwide to live healthier, higher-quality lives, particularly by treating and managing sleep and respiratory disorders. The company’s core mission revolves around improving sleep and breathing health, with a strong emphasis on out-of-hospital care. [1, 15, 16, 23, 26]

For physicians, ResMed offers a comprehensive ecosystem of cloud-connected medical devices and intelligent software platforms designed to transform care for patients with conditions such as sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic respiratory diseases. Their product portfolio includes CPAP machines, masks, and life support ventilators, all integrated with digital health technologies for remote patient monitoring and management. This approach aims to enhance patient outcomes, reduce the impact of chronic disease, and lower healthcare costs by enabling more personalized and accessible care in the home or preferred care setting. [3, 7, 15, 16, 26]

ResMed is at the forefront of leveraging artificial intelligence (AI) to further personalize and optimize therapy. A notable recent development is the FDA clearance for its AI-enabled Smart Comfort program, designed to recommend personalized comfort settings for CPAP therapy. This feature utilizes machine learning models trained on extensive real-world sleep data to tailor air pressure based on individual patient needs, aiming to improve therapy initiation, adherence, and overall user experience without altering prescribed therapeutic pressure settings. [18, 20, 22, 24]

What Physicians Need to Know

Specialization: Sleep & Respiratory Care AI
ResMed specializes in AI-powered solutions for sleep and breathing disorders, particularly obstructive sleep apnea (OSA). Their offerings include AI-enabled CPAP therapy devices and digital health platforms aimed at enhancing patient comfort and adherence.
Key Differentiator: Unparalleled Data Lake
ResMed leverages an extensive proprietary data lake, comprising over 20 billion nights of sleep and breathing health data from 28 million patients across 140 countries. This massive dataset fuels their machine learning models for personalized therapy and insights.
Key Differentiator: FDA-Cleared AI Medical Device
ResMed's 'Smart Comfort' (Personalized Therapy Comfort Settings) is the first FDA-cleared, AI-enabled medical device designed to recommend individualized non-prescription comfort settings for CPAP therapy, significantly improving user adaptation and long-term adherence.
Technology Stack: Cloud-Native AI/ML
Their technology backbone is primarily built on Amazon Web Services (AWS), utilizing Amazon SageMaker for AI/ML model development and deployment. Their data lake is also on AWS, connected via AWS Glue, with Snowflake as a key vendor for data warehousing.
Innovation: Generative AI for Patient Engagement
ResMed has introduced 'Dawn,' a generative AI digital concierge that provides real-time, personalized support and information on sleep health and therapy, reducing direct contact center queries.
Ecosystem: Integrated Digital Health Platforms
Their comprehensive digital health ecosystem includes cloud-based solutions like AirView (for clinicians), myAir (for patients), and U-Sleep, which are crucial for remote monitoring, patient compliance, and generating recurring revenue streams.
Physician Tip

For physicians, ResMed's AI tools offer significant advantages by streamlining workflows and reducing the need for manual adjustments, particularly during initial CPAP setup and follow-up. The personalized therapy recommendations, driven by AI, lead to higher patient adherence and improved clinical outcomes, allowing clinicians to dedicate more time to critical decision-making and patient support. The vast data insights from their connected devices and platforms can also help in efficiently managing patient populations and identifying those requiring more intensive monitoring. Furthermore, ResMed provides educational programs for primary care physicians on obstructive sleep apnea, enhancing diagnostic and referral protocols.

ResMed's AI-enabled features, such as Smart Comfort, are designed for seamless integration within their existing connected ecosystem, including the myAir app and AirSense 11 devices. The myAir app also integrates with popular wearable devices like Apple and Android smartwatches, allowing for comprehensive sleep stage tracking and personalized coaching. ResMed is actively pursuing further integrations with platforms like Apple HealthKit to expand its digital health reach.

Products by ResMed

1 product in the directory

Personalized Therapy Comfort Settings (PTCS)
ResMed
Clinical Decision Support & Reference
ResMed's Smart Comfort (Personalized Therapy Comfort Settings - PTCS) is an FDA-cleared, AI-enabled digital tool that recommends personalized comfort settings for CPAP therapy, designed to enhance adherence for new users of AirSense 11 devices.

What the Web Says

ResMed generally receives positive reviews for its innovative CPAP machines and masks, with users often praising their effectiveness, quiet operation, and portability for travel. However, a recurring theme in customer feedback highlights significant issues with customer service, warranty claims, and the functionality of their MyAir app. Employer reviews are mixed, with some praising work-life balance and benefits, while others point to concerns about management, job security, and a demanding work culture.

Overall: Mixed

Strengths

  • Effective and quiet CPAP therapy machines like the AirSense 11 and AirMini.
  • Portable and lightweight travel CPAP machines (AirMini).
  • Advanced features and user-friendly designs in CPAP machines.
  • MyAir app provides data-driven support and coaching tips (when functional).
  • Good work-life balance and benefits reported by some employees.
  • Supportive colleagues and positive work environment in many departments.

Limitations

  • Inconsistent and often poor customer service.
  • Difficulties with warranty claims and long repair times.
  • MyAir app frequently experiences data syncing delays and other issues.
  • Some CPAP machine models (e.g., AirSense 11) may run out of humidifier water during the night.
  • Concerns about management, job security, and a demanding work culture from some employees.
  • Opaque pricing and difficulty ordering correct replacement parts.

Based on reviews from: Reddit, Indeed.com, Trustpilot, Comparably, BestGuide, Sleep Foundation, Retirement Living, Zippia, Oxygen Times, YouTube

Last updated: 2026-07-19

Videos

News, demos, and interviews about ResMed.

Loading videos...

Videos load interactively. If none appear, search YouTube for ResMed →

View all on YouTube

Press & Coverage

ResMed Investor Relations
ResMed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
ResMed announced FDA clearance for Smart Comfort, an AI-enabled medical device that recommends personalized comfort settings for CPAP therapy, aiming to improve adherence for people with obstructive sleep apnea. This technology leverages machine learning and real-world sleep data to tailor settings for individual users.
2025-12
Fierce Biotech
FDA clears ResMed AI for personalizing CPAP settings
The FDA has granted 510(k) clearance to ResMed's Smart Comfort program, an AI-powered solution designed to personalize CPAP machine settings and enhance therapy adherence for individuals with obstructive sleep apnea. The system uses a machine learning model trained on over 100 million real-world sleep recordings.
2025-12
HME News
ResMed highlights AI-driven CPAP tech, competitive bidding win and GLP-1
ResMed is emphasizing its commitment to artificial intelligence to improve CPAP adherence, with CEO Mick Farrell highlighting the Smart Comfort device at the J.P. Morgan Healthcare Conference. The company's first AI-enabled medical device received FDA clearance in late 2025 and is expected to roll out broadly in 2026.
2026-01
ResMed Investor Relations
ResMed Announces Agreement to Sell MatrixCare Business
ResMed has entered into a definitive agreement to sell its MatrixCare software business for $490 million to Frazier Healthcare Partners, aiming to sharpen its focus on sleep and breathing health devices and connected, home-based care.
2026-07
ResMed Investor Relations
ResMed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio
ResMed completed the acquisition of Noctrix Health, a company specializing in a device to treat restless legs syndrome, further expanding ResMed's clinical sleep health portfolio.
2026-06
GlobeNewswire
New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer
A landmark meta-analysis published in The Lancet Respiratory Medicine, supported by ResMed, found that CPAP therapy significantly reduces the risk of death for people with obstructive sleep apnea, analyzing data from over 1 million patients worldwide.
2025-03
FDA
ResMed Ltd. Recalls Continuous Positive Airway Pressure (CPAP) Masks with Magnets due to Possible Magnetic Interference with Certain Medical Devices
ResMed issued a recall for CPAP masks with magnets due to potential magnetic interference with certain medical devices, which could disrupt their function or position and cause serious harm. The recall updates labels with more warnings and information for safe usage.
2024-01
Seeking Alpha
ResMed downgraded at RBC Capital Markets on FY27 challenges
RBC Capital Markets downgraded ResMed to Sector Perform from Outperform, citing anticipated challenges in fiscal year 2027, including a negative impact on device sales due to an FDA alert for older ventilators and potential re-entry of a competitor into the U.S. sleep-device market.
2026-07

Frequently Asked Questions

ResMed offers AI-powered solutions such as the myAir app for personalized coaching, the generative AI assistant 'Dawn' for patient support, and the FDA-cleared 'Smart Comfort' feature for individualized CPAP comfort settings. These solutions leverage machine learning and extensive de-identified sleep data to enhance therapy adherence, streamline device setup for clinicians, and provide data-driven insights for remote patient monitoring through platforms like AirView.
ResMed is committed to patient data privacy and security, adhering to regulations such as GDPR and MDR, and has achieved ISO 27001 certification for its AirView and myAir solutions. The company implements stringent security and privacy protocols, and its privacy policies detail how personal and consumer health data is collected, used, and disclosed, including provisions for legal and compliance obligations.
ResMed's revenue model combines device sales, recurring consumables, and SaaS subscriptions for its digital health platforms. While specific AI feature pricing isn't always public, their monetization strategy blends hardware margins with high-margin recurring supplies and growing digital health services, which contribute to patient adherence and telehealth revenue. Healthcare organizations can assess ROI by considering improved patient outcomes, increased therapy adherence, and potential reductions in administrative burden and manual adjustments for clinicians.
ResMed provides comprehensive clinical and technical support, including a dedicated Technical Care Team and training resources for healthcare professionals. Their AI-powered digital assistant, 'Dawn,' offers 24/7 product and service support, and features like 'Smart Comfort' are designed to simplify device setup and follow-up, allowing clinicians more time for direct patient care.
Yes, ResMed actively engages in partnerships to advance its AI capabilities and expand its ecosystem. Notably, they collaborate with Samsung to integrate consumer wearables for sleep apnea detection and treatment, and work with research institutions like MIT LGO for talent in AI/ML and data science. ResMed's Sleep Institute also partners with clinicians, researchers, and policymakers to advance sleep health.
ResMed's '2030 Strategy' outlines a long-term vision focused on growth, profitability, and innovation, with significant investment in digital health technologies and AI/ML to enhance therapy performance and user experience. The company aims to expand its market into broader sleep and breathing health areas and has demonstrated strong financial performance, underpinning its commitment to ongoing support and development of its AI platforms.

Investors

Who's funded ResMed.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.